LUMOS PHARMA INC - Common Stock (LUMO)

CUSIP: 55028X109

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Common Stock
Shares outstanding
8,122,625
Total 13F shares
2,367,345
Share change
-73,316
Total reported value
$7,518,364
Price per share
$3.18
Number of holders
36
Value change
-$233,151
Number of buys
10
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 55028X109?
CUSIP 55028X109 identifies LUMO - LUMOS PHARMA INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LUMOS PHARMA INC - Common Stock (LUMO) as of Q4 2023

As of 31 Dec 2023, LUMOS PHARMA INC - Common Stock (LUMO) was held by 36 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,367,345 shares. The largest 10 holders included WELLS FARGO & COMPANY/MN, GOLDMAN SACHS GROUP INC, Blackstone Inc., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Acuitas Investments, LLC, Jefferies Financial Group Inc., Lion Point Capital, LP, Greenwich Wealth Management LLC, and BRIDGEWAY CAPITAL MANAGEMENT, LLC. This page lists 36 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.